BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10586242)

  • 1. Characterization of the effect on adhesion of different mutations in myelin P0 protein.
    Filbin MT; Zhang K; Li W; Gao Y
    Ann N Y Acad Sci; 1999 Sep; 883():160-7. PubMed ID: 10586242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin Po protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type Po.
    Zhang K; Filbin MT
    J Neurosci Res; 1998 Jul; 53(1):1-6. PubMed ID: 9670987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B.
    Matsuyama W; Nakagawa M; Takashima H; Osame M
    Acta Neuropathol; 2002 May; 103(5):501-8. PubMed ID: 11935267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, heterologous expression, and adhesive properties of the P(0)-like myelin glycoprotein IP1 of trout CNS.
    Lanwert C; Jeserich G
    Microsc Res Tech; 2001 Mar; 52(6):637-44. PubMed ID: 11276116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain.
    Wong MH; Filbin MT
    J Cell Biol; 1996 Sep; 134(6):1531-41. PubMed ID: 8830780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin protein zero: mutations in the cytoplasmic domain interfere with its cellular trafficking.
    Konde V; Eichberg J
    J Neurosci Res; 2006 May; 83(6):957-64. PubMed ID: 16493674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylation of myelin Po protein is required for adhesion.
    Gao Y; Li W; Filbin MT
    J Neurosci Res; 2000 Jun; 60(6):704-13. PubMed ID: 10861782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing myelin protein zero (P0) in vivo by construction of P0-GFP fusion proteins.
    Ekici AB; Oezbey S; Fuchs C; Nelis E; Van Broeckhoven C; Schachner M; Rautenstrauss B
    BMC Cell Biol; 2002 Nov; 3():29. PubMed ID: 12450416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
    Plaisier E; Mougenot B; Verpont MC; Jouanneau C; Archelos JJ; Martini R; Kerjaschki D; Ronco P
    J Am Soc Nephrol; 2005 Nov; 16(11):3350-6. PubMed ID: 16162811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cellular characterization of two novel MPZ mutations, p.I135M and p.Q187PfsX63.
    Lin KP; Soong BW; Chang MH; Chen WT; Lin JL; Lee WJ; Lee YC
    Clin Neurol Neurosurg; 2012 Feb; 114(2):124-9. PubMed ID: 22018721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression.
    Jaafari MR; Foldvari M
    J Drug Target; 1999; 7(2):101-12. PubMed ID: 10617296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.
    Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM
    Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination.
    Xu W; Shy M; Kamholz J; Elferink L; Xu G; Lilien J; Balsamo J
    J Cell Biol; 2001 Oct; 155(3):439-46. PubMed ID: 11673479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
    Hasse B; Bosse F; Hanenberg H; Müller HW
    Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
    Nowakowski A; Kochański A
    Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin protein zero and membrane adhesion.
    Spiryda LB
    J Neurosci Res; 1998 Oct; 54(2):137-46. PubMed ID: 9788273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the adhesive domains of the myelin Po protein.
    Zhang K; Merazga Y; Filbin MT
    J Neurosci Res; 1996 Sep; 45(5):525-33. PubMed ID: 8875317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells.
    Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():281-93. PubMed ID: 10586253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathies caused by mutations in the myelin protein zero.
    Shy ME
    J Neurol Sci; 2006 Mar; 242(1-2):55-66. PubMed ID: 16414078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin P0: new knowledge and new roles.
    Eichberg J
    Neurochem Res; 2002 Nov; 27(11):1331-40. PubMed ID: 12512938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.